Graham Capital Management’s Transmedics TMDX Stock Holding History

Graham Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$280K	Sell	2,814 -4,971	-64%	-$648K	0.01%	842
2025 Q4	$947K	Sell	7,785 -270	-3%	-$33.9K	0.02%	405
2025 Q3	$904K	Sell	8,055 -12,558	-61%	-$1.47M	0.01%	415
2025 Q2	$2.76M	Sell	20,613 -9,957	-33%	-$1.09M	0.04%	270
2025 Q1	$2.06M	Sell	30,570 -386	-1%	-$26.5K	0.04%	319
2024 Q4	$1.93M	Buy	30,956 +26,596	+610%	+$2.48M	0.03%	300
2024 Q3	$685K	Buy	+4,360	New	+$672K	0.01%	558
2024 Q2	–	Sell	-40,454	Closed	-$2.99M	–	1365
2024 Q1	$2.99M	Buy	+40,454	New	+$3.33M	0.06%	184

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's TMDX Position: Q1 2026 in Review

Graham Capital Management reduced its Transmedics (TMDX) stake by 64% in Q1 2026, selling an estimated $648K and leaving 2,814 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #842.

Graham Capital Management first reported a position in TMDX in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.99M in Q1 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Graham Capital Management held 2,814 shares of Transmedics worth $280K as of Q1 2026.
Graham Capital Management sold 4,971 Transmedics shares in Q1 2026, an estimated $648K.
Transmedics made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #842 holding.
Graham Capital Management first reported a position in Transmedics in Q1 2024 and has held it in 8 quarters since.
Graham Capital Management's Transmedics position peaked at $2.99M in Q1 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.